Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Deferred Taxes (2018 - 2021)

Dna X filings provide 4 years of Deferred Taxes readings, the most recent being -$26000.0 for Q4 2021.

  • On a quarterly basis, Deferred Taxes fell 218.18% to -$26000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$35000.0, a 266.67% decrease, with the full-year FY2025 number at $1.4 million, up 13670.0% from a year prior.
  • Deferred Taxes hit -$26000.0 in Q4 2021 for Dna X, down from -$4000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $244000.0 in Q4 2018 to a low of -$91000.0 in Q3 2018.
  • Median Deferred Taxes over the past 4 years was -$3000.0 (2021), compared with a mean of $15933.3.
  • The widest YoY moves for Deferred Taxes: up 581.82% in 2020, down 875.0% in 2020.
  • Dna X's Deferred Taxes stood at $244000.0 in 2018, then plummeted by 52.46% to $116000.0 in 2019, then plummeted by 81.03% to $22000.0 in 2020, then crashed by 218.18% to -$26000.0 in 2021.
  • The last three reported values for Deferred Taxes were -$26000.0 (Q4 2021), -$4000.0 (Q3 2021), and -$2000.0 (Q2 2021) per Business Quant data.